1 ML angiotensin II 0.5 MG/ML Injection [Giapreza]
- RxCUI
- 2611707
- RxNorm name
- 1 ML angiotensin II 0.5 MG/ML Injection [Giapreza]
- Display name
- 1 ML angiotensin II 0.5 MG/ML Injection [Giapreza]
- Full name
- 1 ML angiotensin II 0.5 MG/ML Injection [Giapreza]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:19
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Giapreza | ANGIOTENSIN II | La Jolla Pharmaceutical Company | c265d69a-3efe-4107-9a9e-e6fd3d531c48 | 2026-07-22 | Warnings, Adverse reactions | 2611707 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c265d69a-3efe-4107-9a9e-e6fd3d531c48 | Giapreza 0.5 MG in 1 ML Injection [PSN] · 1 ML angiotensin II 0.5 MG/ML Injection [Giapreza] [SBD] · 1 ML Giapreza 0.5 MG/ML Injection [SY] · Giapreza 0.5 MG per 1 ML Injection [SY] | 4 | 17 | These highlights do not include all the information needed to use GIAPREZA safely and effectively. See full prescribing information for GIAPREZA. GIAPREZA® (angiotensin II) Injection for Intravenous Infusion Initial U.S. Approval: 2017 | 20241126 |